Cost containment--another view

The New England Journal of Medicine
R Platt

Abstract

There is an emerging public consensus that in a slowly growing economy, the continuing rise in the nation's health-care costs must be moderated. Ginzberg has suggested that we can and must do this without reducing the quality of care we provide and without major changes in the structure or governance of our health-care-delivery system. He implies that we can readily identify and eliminate substantial numbers of useless health-care services. Such an approach to cost containment is almost certain to fail. A successful cost-containment program will include some or all of the following elements: caps on public health expenditures and implicit limits on the quality and accessibility of health care to be provided at public expense, much tighter government regulation of private health-care expenditures, control of the physician supply, and modification of the fee-for-service reimbursement system for physicians and hospitals. Until our society is prepared to accept these kinds of structural changes and their adverse impact, to some degree, on the quality and accessibility of health services, effective cost containment will not occur. Are we ready for these kinds of changes? Should we be? Perhaps we ought to be less concerned about cost...Continue Reading

References

May 9, 1974·The New England Journal of Medicine·J P Bunker, B W Brown
Mar 3, 1983·The New England Journal of Medicine·P Caper, D Blumenthal
Apr 7, 1983·The New England Journal of Medicine·D M Kinzer
Apr 21, 1983·The New England Journal of Medicine·J K Iglehart
Mar 31, 1983·The New England Journal of Medicine·E P MeliaP S Kurokawa
Oct 21, 1982·The New England Journal of Medicine·S Perry
Feb 12, 1981·The New England Journal of Medicine·A A Berk, T C Chalmers
Dec 17, 1981·The New England Journal of Medicine·J P NewhouseR H Brook
May 19, 1983·The New England Journal of Medicine·E Ginzberg
Jul 15, 1982·The New England Journal of Medicine·N PanethM Susser
Dec 18, 1980·The New England Journal of Medicine·W B Schwartz, P L Joskow
Mar 5, 1981·The New England Journal of Medicine·F D French

❮ Previous
Next ❯

Citations

Jan 1, 1985·Social Science & Medicine·D G Hillman, J B Christianson
Dec 17, 1983·Lancet
Feb 23, 1984·The New England Journal of Medicine·J R Jay
Apr 19, 1984·The New England Journal of Medicine·C A LeeH C Thomas
Jan 23, 1986·The New England Journal of Medicine·S Perry
Dec 1, 1984·IEEE Transactions on Bio-medical Engineering·E O Attinger
Sep 1, 1985·The American Journal of Medicine·J A Robbins
Mar 1, 1985·Journal of the American Geriatrics Society·M B Kapp
Dec 5, 1990·Medical Care Review·S Perry, B Pillar
Apr 2, 1987·The New England Journal of Medicine·R Lebow

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.